<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d233" origId="Dienestrol"><sentence id="DrugDDI.d233.s0" origId="s0" text="Drug/ Laboratory Test Interactions Certain endocrine and liver function tests may be affected by estrogen-containing oral contraceptives."><entity id="DrugDDI.d233.s0.e0" origId="s0.p0" charOffset="0-4" type="drug" text="Drug"/><entity id="DrugDDI.d233.s0.e1" origId="s0.p7" charOffset="97-105" type="drug" text="estrogen"/><entity id="DrugDDI.d233.s0.e2" origId="s0.p9" charOffset="117-136" type="drug" text="oral contraceptives"/><pair id="DrugDDI.d233.s0.p0" e1="DrugDDI.d233.s0.e0" e2="DrugDDI.d233.s0.e1" interaction="false"/><pair id="DrugDDI.d233.s0.p1" e1="DrugDDI.d233.s0.e0" e2="DrugDDI.d233.s0.e2" interaction="false"/><pair id="DrugDDI.d233.s0.p2" e1="DrugDDI.d233.s0.e1" e2="DrugDDI.d233.s0.e2" interaction="false"/></sentence><sentence id="DrugDDI.d233.s1" origId="s1" text="The following similar changes may be expected with larger doses of estrogen: - Increased sulfobromophthalein retention"><entity id="DrugDDI.d233.s1.e0" origId="s1.p15" charOffset="67-75" type="drug" text="estrogen"/></sentence><sentence id="DrugDDI.d233.s2" origId="s2" text="."/><sentence id="DrugDDI.d233.s3" origId="s3" text="- Increased prothrombin and factors VII, VIII, IX, and X;"><entity id="DrugDDI.d233.s3.e0" origId="s3.p18" charOffset="12-23" type="drug" text="prothrombin"/><entity id="DrugDDI.d233.s3.e1" origId="s3.p20" charOffset="28-40" type="drug" text="factors VII"/><pair id="DrugDDI.d233.s3.p0" e1="DrugDDI.d233.s3.e0" e2="DrugDDI.d233.s3.e1" interaction="false"/></sentence><sentence id="DrugDDI.d233.s4" origId="s4" text="decreased antithrombin 3;"><entity id="DrugDDI.d233.s4.e0" origId="s4.p26" charOffset="10-22" type="drug" text="antithrombin"/></sentence><sentence id="DrugDDI.d233.s5" origId="s5" text="increased norepinephrine-induced platelet aggregability"><entity id="DrugDDI.d233.s5.e0" origId="s5.p28" charOffset="10-24" type="drug" text="norepinephrine"/></sentence><sentence id="DrugDDI.d233.s6" origId="s6" text="."/><sentence id="DrugDDI.d233.s7" origId="s7" text="- Increased thyroid-binding globulin (TBG) leading to in-creased circulating total thyroid hormone;"><entity id="DrugDDI.d233.s7.e0" origId="s7.p35" charOffset="83-98" type="drug" text="thyroid hormone"/></sentence><sentence id="DrugDDI.d233.s8" origId="s8" text="as measured by PBI, T4 by column, or T4 by radioimmunoassay."><entity id="DrugDDI.d233.s8.e0" origId="s8.p40" charOffset="20-22" type="drug" text="T4"/><entity id="DrugDDI.d233.s8.e1" origId="s8.p43" charOffset="37-39" type="drug" text="T4"/><pair id="DrugDDI.d233.s8.p0" e1="DrugDDI.d233.s8.e0" e2="DrugDDI.d233.s8.e1" interaction="false"/></sentence><sentence id="DrugDDI.d233.s9" origId="s9" text="Free T3 resin uptake is decreased, reflecting the elevated TBG;"/><sentence id="DrugDDI.d233.s10" origId="s10" text="free T4 concentration is unaltered"/><sentence id="DrugDDI.d233.s11" origId="s11" text="."/><sentence id="DrugDDI.d233.s12" origId="s12" text="- Impaired glucose tolerance"/><sentence id="DrugDDI.d233.s13" origId="s13" text="."/><sentence id="DrugDDI.d233.s14" origId="s14" text="- Decreased pregnanediol excretion"/><sentence id="DrugDDI.d233.s15" origId="s15" text="."/><sentence id="DrugDDI.d233.s16" origId="s16" text="- Reduced response to metyrapone test"/><sentence id="DrugDDI.d233.s17" origId="s17" text="."/><sentence id="DrugDDI.d233.s18" origId="s18" text="- Reduced serum folate concentration"/><sentence id="DrugDDI.d233.s19" origId="s19" text="."/><sentence id="DrugDDI.d233.s20" origId="s20" text="- Increased serum triglyceride and phospholipid concentration."><entity id="DrugDDI.d233.s20.e0" origId="s20.p62" charOffset="35-47" type="drug" text="phospholipid"/></sentence></document>